Influence of Age on the Efficacy and Safety of Spironolactone in Heart Failure with Preserved Ejection Fraction
We examined efficacy and safety of spironolactone by age in the Americas region (N=1767) of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Orly Vardeny, Muthiah Vaduganathan, Brian Claggett, Akshay S. Desai, Inder S. Anand, Sanjiv J. Shah, Eileen O'Meara, Eldrin F. Lewis, Jean Rouleau, Bertram Pitt, Marc A. Pfeffer, Scott D. Solomon Tags: 027 Source Type: research